Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Endoxana
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Endoxana 1g powder for solution for injection vials
0801010H0BBAFAD
|
Endoxana | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Endoxana 200mg powder for solution for injection vials
0801010H0BBADAB
|
Endoxana | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Endoxana 500mg powder for solution for injection vials
0801010H0BBAEAC
|
Endoxana | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Endoxana 50mg tablets
0801010H0BBABAF
|
Endoxana | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.